Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment of PIK3CA
.
Show all posts
Showing posts with label
Treatment of PIK3CA
.
Show all posts
Monday, April 11, 2022
FDA Approves Vijoice (alpelisib) for the Treatment of PIK3CA-Related Overgrowth Spectrum (PROS)
›
Novartis announced the U.S. Food and Drug Administration (FDA) granting accelerated approval to Vijoice ® (alpelisib) for the treatmen...
›
Home
View web version
